DK0804483T3 - Isolerede peptider, der er afledt fra MAGE-tumorafstødelsesantigenprækursorer, som komplekserer med HLA-A2-molekyler - Google Patents

Isolerede peptider, der er afledt fra MAGE-tumorafstødelsesantigenprækursorer, som komplekserer med HLA-A2-molekyler

Info

Publication number
DK0804483T3
DK0804483T3 DK95914838T DK95914838T DK0804483T3 DK 0804483 T3 DK0804483 T3 DK 0804483T3 DK 95914838 T DK95914838 T DK 95914838T DK 95914838 T DK95914838 T DK 95914838T DK 0804483 T3 DK0804483 T3 DK 0804483T3
Authority
DK
Denmark
Prior art keywords
hla
molecules
complex
peptides derived
isolated peptides
Prior art date
Application number
DK95914838T
Other languages
Danish (da)
English (en)
Inventor
Thierry Boon-Falleur
Pierre Coulie
Alan Townsend
Judy Bastin
Der Bruggen Pierrce Van
Thomas Gajewski
Cornelis J M Melief
M W Visseren
W M Kast
Original Assignee
Ludwig Inst Cancer Res
Univ Oxford
Univ Leiden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/217,186 external-priority patent/US5585461A/en
Application filed by Ludwig Inst Cancer Res, Univ Oxford, Univ Leiden filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of DK0804483T3 publication Critical patent/DK0804483T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/208—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK95914838T 1994-03-24 1995-03-22 Isolerede peptider, der er afledt fra MAGE-tumorafstødelsesantigenprækursorer, som komplekserer med HLA-A2-molekyler DK0804483T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/217,186 US5585461A (en) 1994-03-24 1994-03-24 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US08/261,160 US5591430A (en) 1994-03-24 1994-06-17 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
US08/290,381 US5851523A (en) 1994-03-24 1994-08-15 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
PCT/US1995/003657 WO1995025740A1 (en) 1994-03-24 1995-03-22 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules

Publications (1)

Publication Number Publication Date
DK0804483T3 true DK0804483T3 (da) 2001-02-12

Family

ID=27396385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95914838T DK0804483T3 (da) 1994-03-24 1995-03-22 Isolerede peptider, der er afledt fra MAGE-tumorafstødelsesantigenprækursorer, som komplekserer med HLA-A2-molekyler

Country Status (16)

Country Link
US (1) US5851523A (zh)
EP (2) EP0804483B1 (zh)
JP (1) JP3536179B2 (zh)
CN (1) CN1151170C (zh)
AT (1) ATE198336T1 (zh)
AU (1) AU698781B2 (zh)
CA (1) CA2186004C (zh)
DE (1) DE69519748T2 (zh)
DK (1) DK0804483T3 (zh)
ES (1) ES2154728T3 (zh)
FI (1) FI963779A (zh)
GR (1) GR3035636T3 (zh)
NO (1) NO963919L (zh)
NZ (1) NZ283587A (zh)
PT (1) PT804483E (zh)
WO (1) WO1995025740A1 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723832B1 (en) * 1996-10-03 2004-04-20 Ludwig Institute For Cancer Research Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof
US5686068A (en) * 1994-03-24 1997-11-11 Ludwig Institute For Cancer Research Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
US5587289A (en) * 1995-03-14 1996-12-24 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof
US5821122A (en) * 1995-06-07 1998-10-13 Inserm (Institute Nat'l De La Sante Et De La Recherche . .) Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
ATE196652T1 (de) * 1996-01-18 2000-10-15 Aventis Pharma Gmbh In kunstlisches rekombinantes substrat ragg-1 und nativem aggrecan zum studium der proteolytischen wirkung von 'aggrecanase' in zellkultursystemen
ATE377022T1 (de) * 1997-06-23 2007-11-15 Ludwig Inst Cancer Res Isolierte decapeptide, die an hla moleküle binden,sowie deren verwendung
US6060284A (en) * 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
US6291430B1 (en) 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US5965535A (en) 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US6716809B1 (en) 1997-09-12 2004-04-06 Ludwig Institute For Cancer Research Mage-A3 peptides presented by HLA class molecules
GB9826143D0 (en) * 1998-11-27 1999-01-20 Ludwig Inst Cancer Res Tumour rejection antigens
EP3184637A1 (en) * 1999-09-09 2017-06-28 Merck Sharp & Dohme Corp. Mammalian interleukin-12 p40 and interleukin b30 complexes, antibodies, uses in pharmaceutical compositions
US7090847B1 (en) * 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
HU230679B1 (en) * 1999-09-09 2017-08-28 Merck Sharp & Dohme Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions
JP2003512057A (ja) * 1999-10-19 2003-04-02 ルードヴィッヒ インスティテュート フォー キャンサー リサーチ Ｍａｇｅ−ａ１２抗原ペプチド及びその利用
US6897288B1 (en) 1999-10-19 2005-05-24 Ludwig Institute For Cancer Research Mage-A12 antigenic peptides and uses thereof
WO2001085932A2 (en) 2000-05-10 2001-11-15 Aventis Pasteur Limited Immunogenic polypeptides encoded by mage minigenes and uses thereof
US7049413B2 (en) 2001-05-18 2006-05-23 Ludwig Institute For Cancer Research MAGE-A3 peptides presented by HLA class II molecules
US20030113919A1 (en) * 2001-08-17 2003-06-19 Aventis Pasteur, Ltd. Immunogenic targets for melanoma
AU2003223527B2 (en) 2002-04-09 2009-01-15 Sanofi Pasteur Limited Modified CEA nucleic acid and expression vectors
AU2003278036B2 (en) * 2002-10-22 2009-12-10 Aventis Pasteur Limited Anti-cancer vaccines and high-dose cytokines as adjuvants
CA2550583C (en) * 2003-10-08 2013-01-15 Sanofi Pasteur, Inc. Modified cea /b7 vector
WO2009039984A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic uses of urocortin ii and kisspeptin ( 27-54 )
CN106117334B (zh) * 2016-06-24 2020-02-11 秦皇岛未名健康城开发有限公司 一种肿瘤抗原mage3的ctl识别表位肽及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342774A (en) * 1991-05-23 1994-08-30 Ludwig Institute For Cancer Research Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
EP0656788B1 (en) * 1992-08-07 2006-10-18 Pharmexa Inc. Hla binding peptides and their uses
US5519117A (en) * 1992-12-22 1996-05-21 Ludwig Institute For Cancer Research Isolated, tyrosinase derived peptides and uses thereof
DE69435292D1 (de) * 1993-03-05 2010-06-17 Epimmune Inc Verfahren zur herstellung von immunogenen hla-a2.1-bindenden peptiden

Also Published As

Publication number Publication date
AU698781B2 (en) 1998-11-05
CA2186004A1 (en) 1995-09-28
US5851523A (en) 1998-12-22
NO963919L (no) 1996-11-20
EP0804483B1 (en) 2000-12-27
CN1151170C (zh) 2004-05-26
ATE198336T1 (de) 2001-01-15
JP3536179B2 (ja) 2004-06-07
CN1150805A (zh) 1997-05-28
AU2192895A (en) 1995-10-09
DE69519748D1 (de) 2001-02-01
FI963779A0 (fi) 1996-09-23
NO963919D0 (no) 1996-09-19
GR3035636T3 (en) 2001-06-29
EP0804483A1 (en) 1997-11-05
EP0804483A4 (en) 1998-05-20
CA2186004C (en) 2008-09-23
EP0960622A3 (en) 1999-12-22
DE69519748T2 (de) 2001-10-18
NZ283587A (en) 1998-04-27
EP0960622A2 (en) 1999-12-01
ES2154728T3 (es) 2001-04-16
WO1995025740A1 (en) 1995-09-28
JPH10504518A (ja) 1998-05-06
PT804483E (pt) 2001-06-29
FI963779A (fi) 1996-09-23

Similar Documents

Publication Publication Date Title
DK0804483T3 (da) Isolerede peptider, der er afledt fra MAGE-tumorafstødelsesantigenprækursorer, som komplekserer med HLA-A2-molekyler
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
CY1108083T1 (el) Αντιγονα και συνθεσεις του neisseria meningitidis
PL374311A1 (en) Methods for purifying protein
DE3750342T2 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
DE69824719D1 (de) Cytokinähnlicher faktor-7 aus säugetieren
DK0723588T3 (da) Activinreceptorlignende kinase (ALK) hörende til TGF-receptorfamilien og/eller BMP-receptorfamilien
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
SE9602496D0 (sv) Method and means for producing a fibrinogen binding protein and its use in biotechnology
FI970071A0 (fi) Eristetty nukleiinihapposekvenssi, joka koodaa HLA-A2:n esittämää tuumorihyljintäantigeeniä
ATE159546T1 (de) Allergene aus roggenspreupollen
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
SE9002213D0 (sv) Albumin binding proteins
DK438883A (da) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl-isoquinoliner, samt fremgangsmaade til fremstilling heraf
ECSP982602A (es) Citoquinas de mamiferos, reactivos relacionados